186 related articles for article (PubMed ID: 31320741)
41. Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma.
Anagnostou T; Yang ZZ; Jalali S; Kim HJ; Larson DP; Tang X; Yu Y; Pritchett JC; Bisneto JV; Price-Troska TL; Mondello P; Novak AJ; Ansell SM
Leukemia; 2023 Jul; 37(7):1485-1498. PubMed ID: 37117318
[TBL] [Abstract][Full Text] [Related]
42. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
43. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: a study by FISH.
Gruszka-Westwood AM; Matutes E; Coignet LJ; Wotherspoon A; Catovsky D
Br J Haematol; 1999 Mar; 104(3):600-4. PubMed ID: 10086800
[TBL] [Abstract][Full Text] [Related]
44. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
45. Clinical and diagnostic relevance of
Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
[No Abstract] [Full Text] [Related]
46. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
47. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.
Algara P; Mateo MS; Sanchez-Beato M; Mollejo M; Navas IC; Romero L; Solé F; Salido M; Florensa L; Martínez P; Campo E; Piris MA
Blood; 2002 Feb; 99(4):1299-304. PubMed ID: 11830479
[TBL] [Abstract][Full Text] [Related]
48. Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.
Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
[TBL] [Abstract][Full Text] [Related]
49. A unique case of IgD-only splenic marginal-zone lymphoma with mutated immunoglobulin genes: ontogenetic implications.
Papadaki T; Stamatopoulos K; Mavrommatis T; Anagnostopoulos A; Anagnostou D
Leuk Res; 2008 Jan; 32(1):155-7. PubMed ID: 17420049
[TBL] [Abstract][Full Text] [Related]
50. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY).
Baró C; Salido M; Espinet B; Astier L; Domingo A; Granada I; Millà F; Carrió A; Costa D; Luño E; Hernández JM; Campo E; Florensa L; Ferrer A; Salar A; Bellosillo B; Besses C; Serrano S; Solé F
Leuk Res; 2008 May; 32(5):727-36. PubMed ID: 18023866
[TBL] [Abstract][Full Text] [Related]
51. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
52. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
53. Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course.
Viaggi S; Abbondandolo A; Carbone M; Ottaggio L; Sessarego M; Zupo S; Zunino A
Cancer Genet Cytogenet; 2004 Jan; 148(2):133-6. PubMed ID: 14734224
[TBL] [Abstract][Full Text] [Related]
54. NF-κB deregulation in splenic marginal zone lymphoma.
Spina V; Rossi D
Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
[TBL] [Abstract][Full Text] [Related]
55. Splenic marginal zone lymphoma: a case report and literature review.
Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
[TBL] [Abstract][Full Text] [Related]
56. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
[TBL] [Abstract][Full Text] [Related]
57. Splenic marginal zone lymphoma: disease features and management.
Matutes E
Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
[TBL] [Abstract][Full Text] [Related]
58. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
59. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.
Ruiz-Ballesteros E; Mollejo M; Rodriguez A; Camacho FI; Algara P; Martinez N; Pollán M; Sanchez-Aguilera A; Menarguez J; Campo E; Martinez P; Mateo M; Piris MA
Blood; 2005 Sep; 106(5):1831-8. PubMed ID: 15914563
[TBL] [Abstract][Full Text] [Related]
60. Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.
Tsimberidou AM; Catovsky D; Schlette E; O'Brien S; Wierda WG; Kantarjian H; Garcia-Manero G; Wen S; Do KA; Lerner S; Keating MJ
Cancer; 2006 Jul; 107(1):125-35. PubMed ID: 16700034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]